
Feb 23 (Reuters) - Novo Nordisk A/S NOVOb.CO:
NOVO NORDISK'S CHIEF SCIENTIFIC OFFICER: ASSUMING THAT THERE IS FURTHER WEIGHT LOSS POTENTIAL TO BE HAD WITH CAGRISEMA
NOVO NORDISK'S CEO: WE STRONGLY BELIEVE THAT CAGRISEMA HAS RIGHT NOW THE BEST WEIGHT EFFICACY THAN ANY PRODUCT CURRENTLY ON THE MARKET
NOVO NORDISK'S CEO: I AM STILL INCREDIBLY OPTIMISTIC ABOUT CAGRISEMA
NOVO NORDISK'S CEO: WE NEED TO BE AWARE THAT THERE IS AN ABNORMALITY WITH HOW THE COMPARATOR DRUG HAS PERFORMED IN THE STUDY
Further company coverage: [NOVOb.CO]